Thomas Ranson

1.2k citations
6 papers · 973 indexed · h-index 6
  • Immunology top 5%
    • Immune Cell Function and Interaction 6
    • T-cell and B-cell Immunology 6
    • IL-33, ST2, and ILC Pathways 1
    • Reproductive System and Pregnancy 1
  • Hematology top 10%
    • CAR-T cell therapy research 1
    • Cytomegalovirus and herpesvirus research 2
    • Exercise and Physiological Responses 1

Thomas Ranson

6 papers receiving 964 citations

Peers

Thomas Ranson
Comparison fields: 5 of 63
  • Immunology 897
  • Hematology 98
  • Oncology 198
  • Virology 16
  • Epidemiology 87
Replace Jason Brady with:
Jason Brady Australia
Sanda Stankovic Australia
Christopher J. Chan Australia
Sally V. Watt Australia
F Le Deist France
Ioannis Tassiulas United States
Valentina Screpanti Sweden
Marko Janke Germany
Thomas H. Chase United States
Lucie Baudino Switzerland
Thomas Ranson relative to Jason Brady Australia Jason Brady's profile →
Citations per field
00.5×1.5×
Jason Brady · 1×
Citations per year

Countries citing papers authored by Thomas Ranson

Since Specialization
Citations

This map shows the geographic impact of Thomas Ranson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ranson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ranson more than expected).

Fields of papers citing papers by Thomas Ranson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Ranson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ranson. The network helps show where Thomas Ranson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Ranson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Ranson Line = papers co-authored together Thomas Ranson links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1 2005227
2 200549
3 2005120
4 2003184
5 2003274
6 2003119

About Thomas Ranson

Thomas Ranson is a scholar working on Immunology, Rehabilitation and Epidemiology, having authored 6 papers that have together received 973 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (6 papers), Cytomegalovirus and herpesvirus research (2 papers), Exercise and Physiological Responses (1 paper), IL-33, ST2, and ILC Pathways (1 paper), CAR-T cell therapy research (1 paper) and Reproductive System and Pregnancy (1 paper). The work is most often cited by research in Immunology (897 citations), Hematology (98 citations) and Oncology (198 citations). Thomas Ranson has collaborated with scholars based in France, Netherlands and Germany. Frequent co-authors include James P. Di Santo, Christian A. J. Vosshenrich, Erwan Corcuff, Odile Richard, Francesco Colucci, Sandrine Samson, Werner Müller, Eleftheria Rosmaraki, Agnès Lehuen and Jan Buer. Their work appears in journals such as The Journal of Immunology, Blood, Proceedings of the National Academy of Sciences and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026